Theravance Biopharma, Inc. (21) | Uncategorized (7)
Recent Contracts
-
Audited financial statements of Theravance Respiratory Company, LLC for the year ended December 31, 2021
(Filed With SEC on February 28, 2022)
-
Offer Letter with Richard Graham August 12, 2015
(Filed With SEC on November 9, 2020)
-
Brett K. Haumann Transfer to Theravance Biopharma UK Ltd. Memo
(Filed With SEC on May 8, 2020)
-
Brett K. Haumann Theravance Biopharma UK Ltd. Contract of Employment
(Filed With SEC on May 8, 2020)
-
First Amendment of Registration Rights Agreement with Glaxo Group Limited
(Filed With SEC on May 8, 2020)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on February 27, 2020)
-
Offer Letter with Andrew Hindman dated May 30, 2019
(Filed With SEC on August 5, 2019)